The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.

Michael P Curry Edward Tam Caitlin SchneiderNoha AbdelgelilTarek Hassanein Nezam H Afdhal

Published in: International journal of hepatology (2024)

Velacur® assessment of liver stiffness measurement and liver attenuation is comparable to results obtained by FibroScan® and is an alternative technology for monitoring liver fibrosis progression in patients with chronic liver disease. This trial is registered with NCT03957070.

Keyphrases

liver fibrosis
study protocol
clinical trial
phase iii
randomized controlled trial
double blind
placebo controlled